An observational study in Cerebral Palsy, Muscle Contraction and Muscle Spasticity, sponsored by Eva Ponten. Recruiting at 1 site in Sweden. Open to participants aged 2 Years to 18 Years. Per ClinicalTrials.gov, last updated 2022-08-11.
Sponsored by Eva Ponten · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 19 studies in Cerebral Palsy with a site in Sweden — 9 open to participants now, 10 under way, none of them phase 3. Cerebral Palsy · Sweden.
Among the 19 studies in Cerebral Palsy with a site in Sweden, this one is the only one that started in 2006, is one of 9 observational ones, and was the 11th registered.
1,942 studies on the registry are indexed under Cerebral Palsy; 456 are open to participants now.
Browse Cerebral Palsy studies →9 of the 19 studies in Cerebral Palsy with a site in Sweden are open now. Recruiting first, the newest first:
Otto Bock Healthcare Products GmbH · Sites in Sweden
Ages 2+
Lund University · Sites in Sweden
Ages 10–16 · Healthy volunteers
Region Skane · Sites in Sweden
Ages 8+
Eva Ponten · Sites in Sweden
Ages 2–18 · Healthy volunteers
Eva Ponten · Sites in Sweden
Ages 2–18
A study can be open while its sites in Sweden have not opened yet or have stopped. Only those recruiting at a site in Sweden →
Of the 271 Cerebral Palsy studies recruiting now, 26 (10%) set no upper age limit and 237 (87%) stop at 75 or younger; 256 take children under 18; 53 take healthy volunteers.
This study: 2 Years to 18 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
19 studies; the count open now beside each. This study's row is marked.
First in 2002; this study’s year is marked. 1 started in 2006.
This study's planned enrollment of 50 is below the median of 63 across 474 observational studies indexed under Cerebral Palsy.
Median enrollment 28 across the 10 interventional studies, 150 across the 9 observational. Of the 7 that completed or were terminated, 1 (14%) have results posted.
This tab as a report to print or save as PDF → With an account.
2 of 19 have an industry lead sponsor. The 10 most frequent:
Eva Ponten is the lead sponsor of 3 studies on the registry; 3 are open to participants now.
Eva Ponten has 3 studies filed under Cerebral Palsy — fewer than ten, so there is no comparison to draw.
6 of the studies in Cerebral Palsy with a site in Sweden that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05867940Region SkaneEffects of Physical Activity on Prescription (PAP) as a Health-enhancing Intervention in People With Disabilities | 2026-12 |
| NCT05497609Eva PontenThe Muscle in Children With Cerebral Palsy - Longitudinal Exploration of Microscopic Muscle Structure. | 2026-12-15 |
| NCT07374432Karolinska InstitutetFull Speed Ahead: For Joyful Movement and Health | 2026-12-30 |
| NCT07025694Lund UniversityExercise Training Among Children With Cerebral Palsy to Increase Health and Well-being - A Feasibility Study | 2026-12-31 |
| NCT05901259Otto Bock Healthcare Products GmbHThe EXOPULSE Study - a Database for Routine Follow-up of Clinical Outcomes | 2027-08-01 |
Add all 6 to your calendar (.ics) → With an account.
Among the 19 studies in Cerebral Palsy with a site in Sweden, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Cerebral palsy (CP) is a motor impairment due to a brain malformation or a brain lesion before the age of two. Spasticity, hypertonus in flexor muscles, dyscoordination and an impaired sensorimotor control are cardinal symptoms. The brain lesion is non-progressive, but the flexor muscles of the limbs will during adolescence become relatively shorter and shorter (contracted), forcing the joints into a progressively flexed position. This will worsen the positions of already paretic and malfunctioning arms and legs. Due to bending forces across the joints, bony malformations will occur, worsening the function even further. Since about 25 years a combination treatment with intramuscular botulinum toxin injections, braces and training has had a tremendous and increasing popularity, although lasting long-term clinical advantage is not yet proven.
Muscle morphology of the biceps brachii and the gastrocnemius muscles:
Cerebral palsy (CP) is a motor impairment due to a brain malformation or a brain lesion before the age of two. Spasticity, hypertonus in flexor muscles, dyscoordination and an impaired sensorimotor control are cardinal symptoms. The brain lesion is non-progressive, but the flexor muscles of the limbs will during adolescence become relatively shorter and shorter (contracted), forcing the joints into a progressively flexed position. This will worsen the positions of already paretic and malfunctioning arms and legs. Due to bending forces across the joints, bony malformations will occur, worsening the function even further. Currently, the initial treatment of choice is the use of braces, which diminishes the shortening somewhat. Since about 25 years a combination treatment with intramuscular botulinum toxin injections, braces and training has had a tremendous and increasing popularity, although lasting long-term clinical advantage is not yet proven.
Muscle morphology of the biceps brachii and the gastrocnemius muscles:
Significance: Children with cerebral palsy have a motor impairment and progressive contractures that we often treat late; when tendon and bony surgery are the only options to realign the joints. Our aim is to treat the muscles early, so that the contractures and the bony malformations won't occur in the first place. Training and splints, with botulinum toxin as adjuvant treatment, is a very popular regime with this aim, but the long-term effect on muscle tissue and function is not yet known. This study will elucidate the effect during a 2-year period, and no such studies have yet been published. More knowledge is warranted regarding the actual molecular process in the muscle leading to a contracture, and its relation to the constant communication with the injured central nervous system. This study will give answers that could result in new, early prophylactic treatment of joint movement restrictions and motor impairment in children with CP.
Children with cerebral palsy and aquired brain injury who, as a part of care as usual, gets botulinum toxin injections in muscles. Children are recruited consecutively.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
No intervention
Muscle fiber area
um2, square micrometers, measured on specimens
Time frame: Biopsies are collected and stored in -80° freezer and then analyzed. Analyses will take place up to 20271215
Muscle fiber types based on myosin heavy chain isoforms
Percentage of all fibers
Time frame: Biopsies are collected and stored in -80° freezer and then analyzed. Analyses will take place up to 20271215
Extracellular matrix, area
um2, square micrometers, measured on specimens
Time frame: Biopsies are collected and stored in -80° freezer and then analyzed. Analyses will take place up to 20271215
Capillaries per fiber area
number of capillaries/um2
Time frame: Biopsies are collected and stored in -80° freezer and then analyzed. Analyses will take place up to 20271215
Mitochondria: NADH staining, morphology
Scoring 1, 2, 3
Time frame: Biopsies are collected and stored in -80° freezer and then analyzed. Analyses will take place up to 20271215
Clinical assessment, contracture
°, degrees
Time frame: At 0 months, 6 months, 12 months and 24 months
Plan to share: Undecided
No publications or documents are linked to this record.
Started Jan 2006 (actual). Primary completion is estimated for Dec 2026, 251 months after the start.
Of 217 non-industry observational studies under Cerebral Palsy, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 60. This study's planned 251 months is above that.
Counting every sponsor, half of 221 studies reached it within 21 months; a quarter within 8 and three quarters within 60.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.